RxDoctor Payments Data

Vincent Dalessandro, DO

Internal Medicine · Chesterland, OHNPI 1023000221

Payments from drug & device makers

$282in general payments, 2019–2025

Across 15 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$49
  • Abbott$44
  • Novo Nordisk$43
  • AbbVie$39
  • Pfizer$35
  • Otsuka America Pharmaceutical, Inc.$29
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$282100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$282 in reported general payments places this provider in the 55th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$93,579
Medicare patients
483
Services billed
1,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin159$208,836
EliquisApixaban180$201,672
OzempicSemaglutide61$68,112
RybelsusSemaglutide18$41,826
MounjaroTirzepatide35$38,494
TrulicityDulaglutide17$24,478
XareltoRivaroxaban30$23,034
TradjentaLinagliptin16$22,577
Nurtec OdtRimegepant Sulfate11$20,416
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr36$19,068
FarxigaDapagliflozin Propanediol12$14,757
Spiriva RespimatTiotropium Bromide27$13,945
Incruse ElliptaUmeclidinium Bromide16$8,451
Atorvastatin Calcium868$8,187
Breo ElliptaFluticasone/Vilanterol18$8,089

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$35$222,088191 claims
Novo NordiskOzempic, Rybelsus$43$109,93879 claims
Lilly USA, LLCMounjaro, Trulicity$49$62,97252 claims
AbbVieLinzess, Synthroid$39$11,406100 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Chesterland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →